Marc Davies

Director Value and Access, UK

About Marc Davies

Marc brings over twenty years of Pharmaceutical and Market Access experience of negotiating with Payers at a local and regional level on early access to medicine schemes, commercial rebates, patient access schemes, zero cost schemes and service redesign.  Marc’s experience in Market Access extends to the preparation of relevant payer value story’s, driving and setting up of market access focused advisory boards, developing and supporting the market access story prior and post product launch with a high cost medicine, and has been the company link with agencies to support and drive their market access strategy.

 Marc was also chosen as the founding representative for Ethical Medicines in Industry Group (EMIG) on the TDA partnership which liaises directly with the All Wales Medicines Strategy Group (AWMSG) within NHS Wales. He has had several years’ experience working with Clinical Commissioning Groups (CCG’s) and local area teams in England to successfully deliver programs focused on NHS, commercial and patient outcomes across the system.